Hemodynamics of Angiotensin Converting Enzyme Inhibitors

Masami UECHI

doi:10.11276/jsvc1984.31.53

アンギオテンシン変換酵素阻害薬の血行動態

上地正実

著者情報

ジャーナルフリー

1998 年 31 巻 2 号 p. 53-58

DOI https://doi.org/10.11276/jsvc1984.31.53

詳細

発行日: 1998 年受付日: - J-STAGE公開日: 2009/09/17 受理日: - 早期公開日: - 改訂日: -
訂正情報
訂正日: 2009/09/17 訂正理由: - 訂正箇所: 引用文献情報訂正内容: Wrong : 1) The consensus trail study group (1987): Effect of enalapril on mortality in severe congestive heart failure, results of the cooperative north scandinavian enalapril survival study (CONSEN- SUS). N. Eng. JMed., 316, 1429-1435.
2) The IMPROVE study group (1995): Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with Naturally acquired heart failure: results of the Invasive Multicenter PROspective VEterinary evaluation of enalapril study. J. Vet. Intern. Med., 9, 234-242.
3) The COVE study group (1995): Controlled clinical evaluation of enalapril in dogs with heart failure: results of the coopeative veterinary enalapril study group. J. Vet. Intern. Med., 9, 243-252.
4) Uechi, M., Sato, N., Asai, K., Patrick, T., Vatner, S. F. (1998): Voltage-dependent calcium channel promoter restores baroreflex sensitivity in conscious dogs with heart failure. Circulation, 98,1342-1347.
5) Grassi, G., Giannattasio, C., Failla, M., Pesenti, A., Peretti, G., Marinoni, E., Fraschini, N., Vailati, S., Mancia, G.(1995): Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension, 26, 348-354.
7) Kostis, J.B. (1989): Pharmacological differentiation of angiotensin-converting enzyme inhibitors. J. Human Hyperten, 3, 119-125.
8) Wei, L., et al.(1991): The two homologous domains of human angiotensin I convertingenzyme are both catalyhcally achive. J. Bio. Chem.,266,9002.
10) Clavell, A.L., Mattingly, M.T., Stevens, T.L., Nir, A., Wright, R.S., Aarhus, L.L., Heublein, D.M., Burnett, J.C.(1996): Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. J. Clin. Invest., 97, 1286-1292.
11) Blais, C., Drapeau, G., Raymond, P., Lamontagne, D., Gervais, N., Venneman, I., Adam, A. (1997): Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study. Am. J. Pbysiol., 273, H2263- H2271.
12) Kobori, H., Ichihara, A., Suzuki, H., Takenaka T., Miyashita, Y., Hayashi, M., Saruta, T. (1997): Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am. J. Pbysiol. 273, H593-H599.
13) Iwase, M., Uechi, M., Vatner, D. E., Asai, K., Shannon, RP., Kudej, R. K., Wagner, T. E., Patrick, T. A., Ishikawa, Y., Homcy, C. J., Vatner, S. F. (1997): Cardiomyopathy induced by cardic G.. overexpression. Am. J. Pbysiol., 272, H585-H589.
14) Schultz, D., Su, X., Bishop, S.P., Billadello, J., Dell'Italia, L.J. (1997): Selective induction of the creatinine kinase-B gene in chronic volume over-load hypertrophy is not affected by ACE-inhibitor therapy. J. Mol. Cell. Cardiol., 29, 2665-2673.
15) Lear, W., Ruzicka, M., Leenen, F. H. H. (1997): ACE inhibitors and cardiac ACE mRNA in volume
overload-induced cardiac hypertrophy. Am. J. physiol., 273, H641-H646,.
16) Dell'Italia, L.J., Meng, Q.C., Balcells, E., Straeter-Knowlen, I.M., Hankers, G.H., Dillon, R., Cartee, R.E., Orr, R., Bishop, S.P., Oparil, S., Elton, T.S. (1995): Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am. J. Pbysiol., 269, H2065- H2073.
17) Dell'Italia, L.J., Balcells, E., Meng, Q.C., Su, X., Schultz, D., Bishop, S.P., Machida, N., Straeter-Knowlen, I.M., Hankes, G.H., Dillon, R., Cartee, R.E., Oparil, S. (1997): Volume-overload cardiac hypertrophy is unaffected by ACE inihibitor treatment in dogs. Am. J. Pbysiol., 273, H961-H970.
18) Boemke, W., Seeliger, E., Rothermund, L., Corea, M., Pettker, R., Mollenhauer, G., Reinhardt, H.W. (1995): ACE inhibition prevents Na and water retension and MABP increase during reduction of renal perfusion pressure. Am. J. Pbysiol., 269, R481-R489.
19) Zee, R.Y.L., Rao, V.S., Paster, R.Z., Sweet, C.S., Lindpaintner, K. (1998) Three candidate genes and angiotensin-converting enzyme inhibitorrelated cough. A pharmacogenetic analysis. Hypertension, 31,925-928.
20) Haggstrom, J., Hansson, K., Karlberg, B.E., Kvart, C., Madej, A., Olsson, K. (1996): Effects of longterm treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am. J. Vet. Med., 57, 1645-1652.

Right : 1) The consensus trail study group (1987): Effect of enalapril on mortality in severe congestive heart failure, results of the cooperative north scandinavian enalapril survival study (CONSENSUS). N. Eng. J. Med., 316, 1429-1435.
2) The IMPROVE study group (1995): Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with Naturally acquired heart failure: results of the Invasive Multicenter PROspective VEterinary evaluation of enalapril study. J. Vet. Intern. Med., 9, 234-242.
3) The COVE study group (1995): Controlled clinical evaluation of enalapril in dogs with heart failure: results of the coopeative veterinary enalapril study group. J. Vet. Intern. Med., 9, 243-252.
4) Uechi, M., Sato, N., Asai, K., Patrick, T., Vatner, S. F. (1998): Voltage-dependent calcium channel promoter restores baroreflex sensitivity in conscious dogs with heart failure. Circulation, 98,1342-1347.
5) Grassi, G., Giannattasio, C., Failla, M., Pesenti, A., Peretti, G., Marinoni, E., Fraschini, N., Vailati, S., Mancia, G.(1995): Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension, 26, 348-354.
7) Kostis, J.B. (1989): Pharmacological differentiation of angiotensin-converting enzyme inhibitors. J. Human Hyperten, 3, 119-125.
8) Wei, L., et al.(1991): The two homologous domains of human angiotensin I converting-enzyme are both catalyhcally achive. J. Bio. Chem.,266,9002.
10) Clavell, A.L., Mattingly, M.T., Stevens, T.L., Nir, A., Wright, R.S., Aarhus, L.L., Heublein, D.M., Burnett, J.C.(1996): Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. J. Clin. Invest., 97, 1286-1292.
11) Blais, C., Drapeau, G., Raymond, P., Lamontagne, D., Gervais, N., Venneman, I., Adam, A. (1997): Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study. Am. J. Physiol., 273, H2263- H2271.
12) Kobori, H., Ichihara, A., Suzuki, H., Takenaka T., Miyashita, Y., Hayashi, M., Saruta, T. (1997): Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am. J. Physiol. 273, H593-H599.
13) Iwase, M., Uechi, M., Vatner, D. E., Asai, K., Shannon, RP., Kudej, R. K., Wagner, T. E., Patrick, T. A., Ishikawa, Y., Homcy, C. J., Vatner, S. F. (1997): Cardiomyopathy induced by cardic G.. overexpression. Am. J. Physiol., 272, H585-H589.
14) Schultz, D., Su, X., Bishop, S.P., Billadello, J., Dell'Italia, L.J. (1997): Selective induction of the creatinine kinase-B gene in chronic volume over-load hypertrophy is not affected by ACE-inhibitor therapy. J. Mol. Cell. Cardiol., 29, 2665-2673.
15) Lear, W., Ruzicka, M., Leenen, F. H. H. (1997): ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Am. J. physiol., 273, H641-H646,.
16) Dell'Italia, L.J., Meng, Q.C., Balcells, E., Straeter-Knowlen, I.M., Hankers, G.H., Dillon, R., Cartee, R.E., Orr, R., Bishop, S.P., Oparil, S., Elton, T.S. (1995): Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am. J. Physiol., 269, H2065- H2073.
17) Dell'Italia, L.J., Balcells, E., Meng, Q.C., Su, X., Schultz, D., Bishop, S.P., Machida, N., Straeter-Knowlen, I.M., Hankes, G.H., Dillon, R., Cartee, R.E., Oparil, S. (1997): Volume-overload cardiac hypertrophy is unaffected by ACE inihibitor treatment in dogs. Am. J. Physiol., 273, H961-H970.
18) Boemke, W., Seeliger, E., Rothermund, L., Corea, M., Pettker, R., Mollenhauer, G., Reinhardt, H.W. (1995): ACE inhibition prevents Na and water retension and MABP increase during reduction of renal perfusion pressure. Am. J. Physiol., 269, R481-R489.
19) Zee, R.Y.L., Rao, V.S., Paster, R.Z., Sweet, C.S., Lindpaintner, K. (1998) Three candidate genes and angiotensin-converting enzyme inhibitor-related cough. A pharmacogenetic analysis. Hypertension, 31,925-928.
20) Haggstrom, J., Hansson, K., Karlberg, B.E., Kvart, C., Madej, A., Olsson, K. (1996): Effects of longterm treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am. J. Vet. Med., 57, 1645-1652.

抄録

アンギオテンシン変換酵素阻害薬は,まだ不明な点も多くさらなる研究を必要とするが,その効果については多くの臨床例で認められている。心不全の治療薬としては,その安全性の高さや治療効果から第一選択薬としての地位を獲得していると考えられる。

責任著者(Corresponding author)

訂正情報

J-STAGEへの登録はこちら（無料）